Feed PHARM.AS
PH
Pharming Group N.V.
PHARM.AS · AMS
0.99 € -3.09% (-0.03 €)
1M -9.50%
Market Cap $818.7M
P/E Ratio 70.17x
Div. Yield -
ROE 4.63%
Bulios Fair Price
1.41 €
42.1% upside
Preț actual
0.99 €
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile PHARM.AS sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Piotroski F-Score Moderate
5/9Valuation
38 /100
Fair P/S 2.32x
P/E 70.17x
P/B 3.05x
Growth
68 /100
Growing FCF growth 34.75%
EPS growth 35.39%
Book val. growth 10.63%
Profitability
59 /100
Moderate Op. margin 6.56%
Gross margin 88.48%
FCF margin 14.40%
Quality
25 /100
Poor ROA 2.39%
ROIC 3.60%
Asset turnover 0.72x
Debt
70 /100
Low Int. coverage 2.29x
Debt/Equity 0.43x
Net debt/EBITDA 1.92x
Stability
33 /100
Unstable EPS volatility 155.03%
Beta 0.09x
Profitable years 1
Întreabă StockBot despre PHARM.AS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Fabrice Chouraqui
Employees
407
Headquarters
Leiden
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report